Tesla just hit a $1 trillion market cap as Trump's win powers a stock surgeByBruce Gil and William GavinUpdatedNovember 8, 2024
Netflix, Disney+, Hulu, and 5 other major streaming services ranked by priceByBruce GilPublishedNovember 8, 2024
A stronger Ozempic, Wegovy sales boom, and Hims' generic weight loss drug: Pharma news roundupByBruce GilPublishedNovember 8, 2024
The FDA wants to ban a common ingredient in over-the-counter cold and allergy medicationsByBruce GilPublishedNovember 7, 2024
Now playing Sales of Novo Nordisk’s blockbuster weight loss drug Wegovy continue to soarPublishedNovember 6, 2024
Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drugByBruce GilPublishedNovember 4, 2024
Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round upByBruce GilPublishedNovember 1, 2024
Knockoff weight loss drugs are having a moment. Eli Lilly isn't worriedByBruce GilPublishedOctober 30, 2024
Eli Lilly isn't selling as much Zepbound as expected — and the stock is sinkingByBruce GilUpdatedOctober 30, 2024
